Jason Aryeh

Director, Ligand Pharmaceuticals; Director, Orchestra BioMed Holdings, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.3M

Companies

Latest trade

Jun 11, 2026

Companies

Ligand PharmaceuticalsDirector −$1.3M Orchestra BioMed Holdings, Inc.Director +$0.0M

Trades

LGND Sold 4,500 shares at $250.00 $1.1M Jun 11

LGND Sold 500 shares at $250.00 $0.1M Jun 10

OBIO Bought 665 shares at $3.75 $0.0M May 18

OBIO Bought 8,971 shares at $3.90 $0.0M May 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.